Watching stories to help decide on a stem cell transplant
Part of Blood & lymphatic, Cancer clinical trials.
This study tests if watching short videos made by other people who faced the same decision can help you and your family feel more prepared when choosing whether to have a stem cell transplant (also called alloHCT) for your blood cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 21 years old
- You have a myeloid cancer like AML, MDS, myelofibrosis, CML, or MDS/MPN
- Your doctor has suggested a stem cell transplant from a donor (alloHCT)
- You can speak English well enough to watch videos
- You have a family member, partner, or friend who helps you with health decisions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a telehealth (video or phone) program that helps people with certain blood cancers plan their future care preferences. It may help you and your chosen support person communicate your wishes clearly, especially if you become too sick to speak for yourself.
This study looks at whether a physical activity program and related study measures can improve thinking and memory in older adults around the time of a stem cell transplant. If you qualify and participate, the team will compare outcomes between groups to see what approach works best.
This study tests a support program to help patients and their caregivers cope with the stress of a stem cell transplant. It aims to reduce health problems and improve recovery.
This study is testing a new way to explain clinical trial information to people using a video or online tool, to see if it helps them understand better. You may be able to join if you are an English-speaking adult living in the U.S.
This study looks at a family communication tool for children and teens getting stem cell transplants or cellular therapy. It helps families talk about treatment together.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
Hear when a new Myeloid Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.